Scholl Hendrik Peter

Chief Medical Officer · SEC CIK 2113223
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$2.86M
13 trades
Net flow
−$2.86M
Net selling
Total filings
13
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 4d ago ΔOwn −0.4%

Scholl Hendrik Peter sold $13.8K of BLTE.

−$13.8K
96 sh @ $144
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 4d ago ΔOwn −15%

Scholl Hendrik Peter sold $542.2K of BLTE, trimming their stake 15%.

−$542.2K
3,748 sh @ $145
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 4d ago ΔOwn −23%

Scholl Hendrik Peter sold $707K of BLTE, trimming their stake 23%.

−$707K
4,861 sh @ $145
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 4d ago ΔOwn −7.4%

Scholl Hendrik Peter sold $175.3K of BLTE, trimming their stake 7%.

−$175.3K
1,199 sh @ $146
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 4d ago ΔOwn −0.6%

Scholl Hendrik Peter sold $14.1K of BLTE, trimming their stake 1%.

−$14.1K
96 sh @ $147
Advertisement
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −5.9%

Scholl Hendrik Peter sold $282.6K of BLTE, trimming their stake 6%.

−$282.6K
2,054 sh @ $138
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −2.4%

Scholl Hendrik Peter sold $108.3K of BLTE, trimming their stake 2%.

−$108.3K
784 sh @ $138
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −9.8%

Scholl Hendrik Peter sold $438.3K of BLTE, trimming their stake 10%.

−$438.3K
3,140 sh @ $140
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −1.9%

Scholl Hendrik Peter sold $75.9K of BLTE, trimming their stake 2%.

−$75.9K
540 sh @ $141
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −0.4%

Scholl Hendrik Peter sold $14.2K of BLTE.

−$14.2K
100 sh @ $142
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −1.6%

Scholl Hendrik Peter sold $64K of BLTE, trimming their stake 2%.

−$64K
450 sh @ $142
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −6.8%

Scholl Hendrik Peter sold $272.3K of BLTE, trimming their stake 7%.

−$272.3K
1,897 sh @ $144
BLTE
Sell Scholl Hendrik Peter · Chief Medical Officer · Open-market sale · filed 1w ago ΔOwn −4.0%

Scholl Hendrik Peter sold $150.1K of BLTE, trimming their stake 4%.

−$150.1K
1,035 sh @ $145

Frequently asked questions

How is Scholl Hendrik Peter's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Scholl Hendrik Peter's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.